Soon-to-be-published consensus report will remove glucose from the definition of diabetic ketoacidosis in people with diabetes, among many other changes since the last statement in 2009.
The American Diabetes Association Scientific Sessions will feature results from multiple incretin drug trials, data on bariatric surgery versus lifestyle management, new interactive debates, and much more.
Observational data show that certain types of sulfonylureas for the treatment of type 2 diabetes are associated with more cardiovascular events compared to other types, such as glimepiride.